PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Down 44.9% in June

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant drop in short interest during the month of June. As of June 30th, there was short interest totaling 331,075 shares, a drop of 44.9% from the June 15th total of 601,191 shares. Currently, 28.6% of the shares of the company are sold short. Based on an average daily volume of 387,077 shares, the days-to-cover ratio is presently 0.9 days.

PMGC Stock Performance

Shares of PMGC stock traded down $0.03 during midday trading on Friday, hitting $1.06. The company had a trading volume of 596,664 shares, compared to its average volume of 4,769,266. The business’s 50 day simple moving average is $1.50 and its two-hundred day simple moving average is $7.91. The stock has a market cap of $1.23 million, a PE ratio of -0.01 and a beta of -0.23. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.45 and a quick ratio of 1.43. PMGC has a 1-year low of $1.02 and a 1-year high of $309.12.

PMGC (NASDAQ:ELAB) last released its earnings results on Thursday, May 14th. The company reported ($11.22) EPS for the quarter. The company had revenue of $0.68 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research report on Friday, June 26th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, PMGC has a consensus rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.